ImportantUpdates
Thyrocare's promoter, Docon Technologies, sold 1.58 Cr shares, reducing its stake from 60.92% to 51.02%. This represents 9.90% of total equity.
Thyrocare Technologies LimitedTHYROCARE · Filed with the exchange
Docon remains a promoter.
No comments yet. Be the first.